Effect of Black Cumin (Nigella sativa) on Prostate Health: Narrative Review

4.1 Traditional uses of black cumin

Nigella sativa, also known as black seed or black cumin in English, Habat Al-Baraka in Arabic, and Tikur azmud in Amharic, has a long history of widespread culinary use. It has been employed as a spice and flavoring agent in a variety of dishes, including bread, yogurt, pickles, sauces, and salads.³² This versatile seed has also held a prominent place in traditional remedies across Arabian countries, Far East Asia, Europe, and Africa, earning it the nickname “The herb from heaven” by early herbal specialists.³³ The Prophet Mohammed (PBUH) acknowledged its medicinal virtues, saying, “Hold on to the use of this black seed, as it has a remedy for every illness except death.”³⁴ Furthermore, Avicenna, a renowned physician from the 10th century, known for his work “The Canon of Medicine,” advocated Nigella seeds for enhancing the body’s energy and assisting recovery from exhaustion and dispiritedness. Notably, the Holy Bible mentions Nigella sativa for its therapeutic properties, and Hippocrates and Dioscorides refer to it as Melanthion.^35,36 Black cumin seeds have numerous medicinal applications in ancient herbal systems and are used to treat a variety of diseases. These include respiratory problems, pain treatment (such as chronic headaches and back pain), diabetes, paralysis, infections, inflammation, hypertension, and digestive system concerns, with various formulations utilized for administration. Furthermore, it has been applied topically for conditions such as blisters, nasal abscesses, orchitis, eczema, and swollen joints.⁹ Considering the extensive history of traditional medicinal uses of Black cumin and their active components such as TQ, there is a compelling reason to explore this valuable herb as an effective herbal medicine with multiple pharmacological actions. Based on the published experimental studies, our review highlights the potential benefits of Black cumin for treating prostate diseases such as BPH and PCa ( Figure 4).

Figure 4. Potential benefits of Nigella sativa seeds on human prostate based on experimental studies.

4.2 Potential efficacy of black cumin for benign prostatic hyperplasia

In 2019, there were an estimated 94 million cases (95% CI 73.2 to 118 million) of BPH cases worldwide. This number marks a significant increase compared to the 51.1 million cases (95% CI 3.1 to 69.3 million) recorded in the year 2000.³⁷ BPH is a prevalent age-related condition of the prostate gland in men and is characterized by symptoms such as urinary tract obstruction, increased urination frequency, urinary retention, diminished urinary tube diameter, altered urine flow pressure, and post-urination dribbling.³⁸ This condition entails enlargement of the prostate gland due to excessive proliferation of cellular components, notably mesenchymal cells. Common therapeutic approaches encompass α-adrenergic antagonists, 5-α-reductase inhibitors, and alternative remedies with natural products.³⁹ Recent research has highlighted the relationship between oxidative stress (OS) and BPH. Notably, patients with BPH exhibit elevated levels of the lipid peroxidation biomarker MDA, coupled with suppressed plasma antioxidant levels.^39,40 This underscores the potential utility of antioxidant interventions in the management of BPH. Nonetheless, conventional treatments such as alpha-adrenergic receptor blockers and 5-alpha reductase inhibitors present side effects and economic constraints, prompting the exploration of natural compounds as lead candidates for drug development or adjunctive therapies. Investigative studies have highlighted promising alternatives and complementary options for managing mild BPH, including Serona repens, Pygeum africanum, and Secale cereals. This approach has gained traction owing to factors such as accessibility, cost-effectiveness, and comparatively superior safety profiles compared to prevailing pharmaceutical interventions. Additionally, the global trend towards harnessing natural sources for the treatment of otherwise challenging diseases has bolstered interest in botanicals and other natural reservoirs, with Nigella sativa emerging as a highly endorsed contender within this paradigm.³⁹

A study using the BPH rat model reported that the administration of Black cumin seed oil at doses of 00 and 800 mg/kg resulted in a discernible reduction in DHT levels.⁶ Intriguingly, these findings indicated that the Black cumin oil, to a certain extent, displayed a more pronounced decrease in DHT levels within the BPH model compared to finasteride.⁶ Similarly, Hiipakka et al. reported that treatment with polyphenols derived from green tea diminished DHT production and hindered prostate cell proliferation. Given Black cumin’s composition of polyphenolic compounds,⁴¹ it stands to reason that the suppression of 5α-reductase activity potentially contributes to the beneficial impacts of this botanical.

Among the fatty acids, Black cumin oil contains a substantial amount of essential unsaturated fatty acids, including approximately 1% omega-3, 25% omega-9, and 58% omega-6.^8,42 Prior work by Abdel-Rahman et al. posited that fatty acid-enriched compounds might impede the proliferation of prostate cells by reducing testosterone and DHT concentrations⁴³ This aligns with the findings of Liang et al., who demonstrated the inhibitory role of fatty acids on 5α-reductase.⁴² Increased prostate weight serves as an indicative marker for diagnosing BPH, and the Prostate Index (PI) is frequently used to gauge BPH progression.⁴⁴ A study on the rat of the model reported that both 00 and 800 mg/kg doses of Black cumin seed oil significantly decreased both PI and PV in the context of BPH.⁶ Recent insights have revealed the potential of PV and PSA concentrations in predicting the growth of prostate cells. Notably, PSA can serve as a surrogate index for PV and as a diagnostic marker for assessing the risk of prostate carcinoma.⁴⁴ Hence, an elevated PSA level corresponds to heightened proliferation of prostate cells. A study on the BPH rat model reported that treatment with N. sativa seed oil at doses of 00 and 800 mg/kg prominently reduced PSA concentrations compared to the BPH model control group.⁶ Ren et al. highlighted the ability of polyphenols to repress PSA gene expression,⁴⁵ suggesting that the ability of N. sativa to reduce PSA levels may be attributed to the presence of polyphenols.⁶

Consequently, the observed effect of N. sativa oil in hindering lipid peroxidation, and by extension, its potential anti-BPH effects, is likely attributable to its reservoir of antioxidant and free-radical-quenching compounds. A study concerning serum MDA levels, further underscored this assertion, as these parameters were notably elevated in the BPH group compared to the control group.⁶ Remarkably, in this animal study, within the N. sativa oil-treated groups, a significant reduction in serum MDA levels was evident compared to the BPH group. This reduction strongly signifies the shielding effects of the constituents present in N. sativa oil, thereby potentially enhancing serum antioxidant capacity and concurrently lowering MDA levels. The observed decline in MDA levels appeared to align with the inherent antioxidant potency of plants.⁶

4.3 Assessing black cumin’s anticancer properties against prostate cancer

The increasing global incidence of cancer poses significant medical challenges. In response, there has been a growing endeavor to explore potent natural anticancer treatments as alternatives to existing chemotherapeutic approaches, which often have limited applicability.

PCa is one of the most prevalent malignancies affecting men,⁴⁶ and recent research has unveiled the noteworthy role of TQ, a prominent bioactive compound in Nigella sativa, in influencing PCa markers ( Table 2). TQ, a pivotal constituent of black seed oil, has a wide spectrum of pharmacological effects including potent anti-inflammatory properties⁴⁷ and notable antioxidant activity.⁴⁸ Furthermore, TQ was the predominant bioactive compound extracted from Black cumin. Its abundance has been linked to its antineoplastic properties against a diverse array of tumors.^49,50 TQ has garnered attention for its antineoplastic properties in various cancers, including pancreatic cancer,⁴⁸ lung cancer, colon cancer,⁵¹ and leukemia.⁵² Research has shown that TQ not only curbs growth and triggers cell apoptosis and cell cycle arrest, but also deters metastasis and angiogenesis. These multifaceted effects are attributed to its modulation of key signaling pathways such as Akt,⁵³ NF-κB,⁵⁴ mitogen-activated protein kinase (MAPK), and Signal transducer and activator of transcription 3 (STAT3).⁵⁵ In this compilation, we have summarized the present scientific knowledge concerning the anticancer properties of Nigella sativa, along with elucidating its mechanism of action, with a specific focus on PCa.

Findings from the study on the effect of TQ on human PCa cell lines DU15 and human prostate cancer cell line (PC3) revealed that TQ effectively curbed the metastatic attributes and restrained the process of epithelial-mesenchymal transition (EMT) within PCa cells through its active downregulation of the TGF-β/Smad2/3 signaling pathway. Furthermore, these outcomes lend support to the proposition that TQ holds promising potential as a therapeutic agent against PCa, functioning by precisely targeting the TGF-β pathway.²² However, the relationship between the TQ and EMT in PCa remains unclear. Furthermore, the precise mechanism underlying TQs inhibition of the metastatic phenotype remains to be fully elucidated.

A study explored the combination of docetaxel and TQ in hormone-refractory prostate cancer cells (DU-15) and its impact on PI3K and ERK signaling pathways tested the effect of PI3K and ERK inhibitors (LY294002 and FR 180204) cells respectively, were treated with the inhibitors for one hour, and then treated with docetaxel in combination with TQ.²³ The combination of docetaxel and TQ showed a significant increase in cytotoxic and apoptotic effects compared to using each agent separately, with the effect becoming stronger at higher doses. Interestingly, the presence of LY294002 did not substantially alter cell viability when combined with docetaxel and TQ, unlike cells treated with LY294002 alone. - However, introducing FR18020 reduced cell viability significantly when combined with docetaxel and TQ, compared to cells treated solely with the inhibitor. The study suggests that the cytotoxic effect of docetaxel and TQ is connected to the inhibition of the PI3K/Akt signaling pathway in DU-15 cells.²³ This combined approach has the potential to offer an alternative to contemporary oncological practices. Additionally, the synergistic use of docetaxel and TQ holds promise for potentially reducing the dosage of docetaxel and mitigating its associated adverse effects while maintaining therapeutic effectiveness for patients with castration-resistant prostate cancer (CRPC).²³

In an in vitro study on human prostate carcinoma LnCaP cells, TQ decreased cell viability and enhanced apoptosis by activating caspase-9.²⁴ TQ significantly reduces cancer cell survival through apoptosis, with its effects being time-dependent and substantial. Moreover, an investigation into the mode of action of TQ in androgen receptor (AR)-naïve (PC-3) and AR-independent (C-2B) PCa cells revealed that TQ inhibited the growth of human prostate C-2B cancer cells by inducing growth arrest, JNK activation, and DNA-damage-inducible 45 alpha (GADD45a), while also downregulating Bcl-2-related proteins, such as BAG-1, Bcl-2, Bcl2A1, Bcl2L1, and BID.²⁵ Moreover, TQ has the ability to inhibit growth in C-2B and PC3 cells by raising reactive oxygen species (ROS) and lowering glutathione (GST) levels in both of these cells.²⁵ TQ-induced cell death is primarily caused by increased ROS generation and decreased GSH levels and is not influenced by AR activity. Furthermore, TQ demonstrated a pro-oxidant cytotoxic mechanism, including oxidative DNA damage, which was enhanced through a copper-dependent pathway by mobilizing and decreasing endogenous cellular copper across multiple PCa cell lines, including DU15, LNCaP, PC3, and C2B.²⁶ This pro-oxidant cytotoxic pathway provides a more thorough understanding of the anticancer efficacy of plant-based antioxidants.²⁶

A study found that TQ, a naturally produced herbal substance, has potential as a treatment for both hormone-sensitive and hormone-refractory PCa. Furthermore, given its specific effect on cancer cells, we believe that TQ could be safely used as a preventive measure against the start of PCa.²⁷ TQ has potential benefits in treating hormone-sensitive and hormone-resistant prostate cancer, and its selective action on cancer cells makes it safely administered to help prevent PCa.

TQ exerts inhibitory effects on the expression of AR and E2F-1, which are crucial for the proliferation and viability of androgen-sensitive and androgen-independent prostate cancer cells, both in vivo and in vitro. The efficacy of TQ is evident in its ability to diminish the levels of AR and E2F-1 while promoting the activation of pro-apoptotic proteins, including p53, p21Cip1, p27Kip1, and Bax, in androgen-sensitive prostate cancer cells.²⁷ TQ inhibited tumor growth in xenografts originating from androgen-independent C-2B prostate cancer cells in nude mice. Consistent with its effect on cultured cells, this outcome correlated with a substantial reduction in AR and E2F-1 expression and the initiation of apoptosis. Consequently, our perspective is that TQ holds promise as a potential therapy for PCa, particularly in hormone-refractory cases.²⁷ Additionally, TQ dose-dependency increased the inhibitory effect of TQ on DNA synthesis, proliferation, and viability of cancerous cells (LNCaP, C-2B, PC-3, and DU15), but not in non-cancerous prostate (BPH-1) epithelial cells.²⁷ Another study reported that TQ effectively blocked angiogenesis both in vitro and in vivo,²⁸ exhibited preventive effects on tumor angiogenesis in the PC3 mouse model, and curbed human prostate tumor growth at a low dose with minimal chemo-toxic side effects. Notably, this study observed a heightened sensitivity of endothelial cells to TQ-induced phenomena, including apoptosis, suppression of proliferation, and hindered migration, in contrast to PC3 cancer cells. Furthermore, TQ effectively restrained the activation of extracellular signal-regulated kinase induced by vascular endothelial growth factor but did not affect the activation of vascular endothelial growth factor receptor 2.²⁸ These findings led to the conclusion that TQ can efficiently inhibit prostate tumor growth at an early tumor stage (50 mm³) at a dose of 6 mg/kg/day.²⁸ A study on the nanoparticle optimization of Nigella sativa reported the successful development and characterization of a nano-based carrier for Nigella sativa essential oil using optimization techniques, and a methyl thiazolyl-diphenyl-tetrazolium bromide (MTT) assay was performed to compare the in vitro cytotoxicity using two different cell lines (i.e., HCT 116 for colorectal carcinoma and PC3 for prostatic cancer). This study demonstrated the enhanced properties of nanoparticulated oil, including improved efficiency in suppressing cancer cell viability compared to free oil.²⁹ Another study reported that TQ can block metastatic processes induced by IL-7 in prostate cancer cells, thereby controlling tumor progression, migration, and invasion.³⁰ An in vitro study found that the combination of TQ and zoledronic acid (ZA) led to increased cytotoxic effects and apoptosis in prostate cancer cell lines resistant to both hormones and drugs. This novel combination approach could serve as an alternative strategy for patients with limited treatment options due to poor performance status and those who are not viable candidates for traditional therapies. In addition, compared with cytotoxic agents, it exhibits a minimal profile of hematological and non-hematological toxicity.³¹

These studies suggest that Black cumin may play a role in slowing the progression of prostate cancer; however, clinical trials in humans are necessary to determine its efficacy and safety. It is important to approach these findings with caution and consult medical professionals before considering complementary or alternative treatments, particularly for serious conditions such as cancer.

Limitation

This review has certain limitations, including issues that may influence its quality, validity, and reliability. However, this is the first paper to provide a complete assessment of the emerging evidence and insights from in vitro and in vivo studies investigating the possible benefit of Black cumin (Nigella sativa L.) on prostate health and disorders such as BPH and PCa.

Recommendation and future directions

Suggestions and possible directions for utilizing the benefits of Black cumin (Nigella sativa L.) in enhancing prostate health might encourage researchers to conduct more rigorous clinical trials to validate the specific effects of Black cumin on prostate health. These studies should include varied populations, long-term assessments, and in-depth study to determine the precise processes by which black cumin chemicals interact with prostate cells and alter hormonal balance.

This information will contribute to a better understanding of their possible therapeutic benefits. Furthermore, we identified the most suitable dosage and time for Black Cumin supplementation to enhance prostate health advantages. This includes looking into both short- and long-term impacts at different dosage levels. In addition, we investigated the synergistic benefits of combining black cumin with known prostate cancer treatments.

This could potentially improve therapeutic success while minimizing side effects. Furthermore, we discovered and isolated the major bioactive components in Black cumin that are responsible for its beneficial benefits on prostate health. This information could lead to the creation of specialized vitamins and treatments. Continued evaluation of the safety profile of black cumin supplementation is required, particularly in the context of long-term use, as well as potential drug interactions. Future efforts should focus on improving its application through research-backed dosages and combination medicines, as well as effectively conveying its potential advantages to the general public and healthcare practitioners.